Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX)
$6.9100
-0.3500 ( -1.99% ) 8.3M
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Market Data
Open
$6.9100
Previous close
$7.2600
Volume
8.3M
Market cap
$2.73B
Day range
$6.7860 - $7.4690
52 week range
$5.6000 - $15.7400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Oct 04, 2024 |
4 | Insider transactions | 1 | Oct 03, 2024 |
8-k | 8K-related | 107 | Oct 02, 2024 |
4 | Insider transactions | 1 | Sep 30, 2024 |
4 | Insider transactions | 1 | Sep 19, 2024 |
prem14a | Proxies and info statements | 21 | Sep 17, 2024 |
4 | Insider transactions | 1 | Sep 12, 2024 |
4 | Insider transactions | 1 | Sep 06, 2024 |
4 | Insider transactions | 1 | Sep 05, 2024 |
8-k | 8K-related | 111 | Sep 03, 2024 |